A novel subset of putative stem/progenitor CD34⁺Oct-4⁺ cells is the major target for SARS coronavirus in human lung
Author(s)
Type
Journal Article
Abstract
Identification of the nature of severe acute respiratory syndrome (SARS)-infected cells is crucial toward understanding the pathogenesis. Using multicolor colocalization techniques, we previously reported that SARS+ cells in the lung of fatally infected patients expressed the only known functional receptor, angiotensin-converting enzyme 2, and also a binding receptor, liver/lymph node–specific ICAM-3–grabbing non-integrin (CD209L). In this study, we show that SARS-infected cells also express the stem/progenitor cell markers CD34 and Oct-4, and do not express cytokeratin or surfactant. These putative lung stem/progenitor cells can also be identified in some non-SARS individuals and can be infected by SARS-coronavirus ex vivo. Infection of these cells may contribute to the loss of lung repair capacity that leads to respiratory failure as clinically observed.
Date Issued
2007-10-08
Date Acceptance
2007-09-07
Citation
Journal of Experimental Medicine, 2007, 204 (11), pp.2529-2536
ISSN
0022-1007
Publisher
Rockefeller University Press
Start Page
2529
End Page
2536
Journal / Book Title
Journal of Experimental Medicine
Volume
204
Issue
11
Copyright Statement
© 2007 Rockefeller University Press
Identifier
http://www.jem.org/cgi/content/abstract/jem.20070462v1
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Medicine, Research & Experimental
Research & Experimental Medicine
ACUTE RESPIRATORY SYNDROME
IN-SITU HYBRIDIZATION
BONE-MARROW
STEM-CELLS
ENDOGENOUS BIOTIN
INFECTION
IDENTIFICATION
LOCALIZATION
PRECURSORS
RHESUS
Aged
Aged, 80 and over
Antigens, CD34
Antigens, Viral
Autopsy
Female
Humans
Keratins
Lung
Male
Middle Aged
Octamer Transcription Factor-3
Pulmonary Alveoli
Pulmonary Surfactants
SARS Virus
Severe Acute Respiratory Syndrome
Stem Cells
11 Medical And Health Sciences
Publication Status
Published